Page 158 - Read Online

Targeting cerebrospinal fluid for discovery of efficiency of gemcitabine as radiosensitizer in the treatment
brain cancer biomarkers of newly diagnosed high-grade glioma patients.
Tarek Shalaby et al. (Switzerland)
This review examines potential and limitations of brain
tumor biomarkers in the CSF. Financial support and sponsorship
Nil.
Gemcitabine followed by radiotherapy in
treatment of newly diagnosed high-grade gliomas
Maha El-Naggar et al. (Egypt) Conflicts of interest
This prospective single centre phase II study evaluated the There are no conflicts of interest.

148
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ May 18, 2016 ¦